Gastrointestinal Stromal Tumor Drug Market
1 Introduction to Research & Analysis Reports
1.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastrointestinal Stromal Tumor (GIST) Drug Overall Market Size
2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size: 2021 VS 2028
2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales: 2017-2028
3 Company Landscape
3.1 Top Gastrointestinal Stromal Tumor (GIST) Drug Players in Global Market
3.2 Top Global Gastrointestinal Stromal Tumor (GIST) Drug Companies Ranked by Revenue
3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Companies
3.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Companies
3.5 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Gastrointestinal Stromal Tumor (GIST) Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gastrointestinal Stromal Tumor (GIST) Drug Players in Global Market
3.8.1 List of Global Tier 1 Gastrointestinal Stromal Tumor (GIST) Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Gastrointestinal Stromal Tumor (GIST) Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Markets, 2021 & 2028
4.1.2 Amcasertib
4.1.3 Anagrelide hydrochloride CR
4.1.4 APG-1351
4.1.5 Binimetinib
4.1.6 Others
4.2 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue & Forecasts
4.2.1 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2017-2022
4.2.2 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2023-2028
4.2.3 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales & Forecasts
4.3.1 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2017-2022
4.3.2 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2023-2028
4.3.3 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2017-2028
4.4 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2021 & 2028
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue & Forecasts
5.2.1 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2017-2022
5.2.2 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2023-2028
5.2.3 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales & Forecasts
5.3.1 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2017-2022
5.3.2 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2023-2028
5.3.3 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2017-2028
5.4 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2021 & 2028
6.2 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue & Forecasts
6.2.1 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2017-2022
6.2.2 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2023-2028
6.2.3 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales & Forecasts
6.3.1 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2017-2022
6.3.2 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2023-2028
6.3.3 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2017-2028
6.4.2 By Country - North America Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2017-2028
6.4.3 US Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.4.4 Canada Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.4.5 Mexico Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2017-2028
6.5.2 By Country - Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2017-2028
6.5.3 Germany Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.5.4 France Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.5.5 U.K. Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.5.6 Italy Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.5.7 Russia Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.5.8 Nordic Countries Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.5.9 Benelux Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2017-2028
6.6.2 By Region - Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2017-2028
6.6.3 China Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.6.4 Japan Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.6.5 South Korea Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.6.6 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.6.7 India Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2017-2028
6.7.2 By Country - South America Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2017-2028
6.7.3 Brazil Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.7.4 Argentina Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2017-2028
6.8.3 Turkey Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.8.4 Israel Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.8.6 UAE Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Ariad Pharmaceuticals, Inc.
7.1.1 Ariad Pharmaceuticals, Inc. Corporate Summary
7.1.2 Ariad Pharmaceuticals, Inc. Business Overview
7.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.1.4 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.1.5 Ariad Pharmaceuticals, Inc. Key News
7.2 Arog Pharmaceuticals, Inc.
7.2.1 Arog Pharmaceuticals, Inc. Corporate Summary
7.2.2 Arog Pharmaceuticals, Inc. Business Overview
7.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.2.4 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.2.5 Arog Pharmaceuticals, Inc. Key News
7.3 Array BioPharma Inc.
7.3.1 Array BioPharma Inc. Corporate Summary
7.3.2 Array BioPharma Inc. Business Overview
7.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.3.4 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.3.5 Array BioPharma Inc. Key News
7.4 Astex Pharmaceuticals, Inc.
7.4.1 Astex Pharmaceuticals, Inc. Corporate Summary
7.4.2 Astex Pharmaceuticals, Inc. Business Overview
7.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.4.4 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.4.5 Astex Pharmaceuticals, Inc. Key News
7.5 Blueprint Medicines Corporation
7.5.1 Blueprint Medicines Corporation Corporate Summary
7.5.2 Blueprint Medicines Corporation Business Overview
7.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.5.4 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.5.5 Blueprint Medicines Corporation Key News
7.6 Boston Biomedical, Inc.
7.6.1 Boston Biomedical, Inc. Corporate Summary
7.6.2 Boston Biomedical, Inc. Business Overview
7.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.6.4 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.6.5 Boston Biomedical, Inc. Key News
7.7 Calithera Biosciences, Inc.
7.7.1 Calithera Biosciences, Inc. Corporate Summary
7.7.2 Calithera Biosciences, Inc. Business Overview
7.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.7.4 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.7.5 Calithera Biosciences, Inc. Key News
7.8 Chipscreen Biosciences Ltd
7.8.1 Chipscreen Biosciences Ltd Corporate Summary
7.8.2 Chipscreen Biosciences Ltd Business Overview
7.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.8.4 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.8.5 Chipscreen Biosciences Ltd Key News
7.9 Deciphera Pharmaceuticals, LLC
7.9.1 Deciphera Pharmaceuticals, LLC Corporate Summary
7.9.2 Deciphera Pharmaceuticals, LLC Business Overview
7.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.9.4 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.9.5 Deciphera Pharmaceuticals, LLC Key News
7.10 F. Hoffmann-La Roche Ltd.
7.10.1 F. Hoffmann-La Roche Ltd. Corporate Summary
7.10.2 F. Hoffmann-La Roche Ltd. Business Overview
7.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.10.4 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.10.5 F. Hoffmann-La Roche Ltd. Key News
7.11 Horizon Pharma Plc
7.11.1 Horizon Pharma Plc Corporate Summary
7.11.2 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Business Overview
7.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.11.4 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.11.5 Horizon Pharma Plc Key News
7.12 Immunicum AB
7.12.1 Immunicum AB Corporate Summary
7.12.2 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Business Overview
7.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.12.4 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.12.5 Immunicum AB Key News
7.13 Jiangsu Hengrui Medicine Co., Ltd.
7.13.1 Jiangsu Hengrui Medicine Co., Ltd. Corporate Summary
7.13.2 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Business Overview
7.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.13.4 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.13.5 Jiangsu Hengrui Medicine Co., Ltd. Key News
7.14 Kolltan Pharmaceuticals, Inc.
7.14.1 Kolltan Pharmaceuticals, Inc. Corporate Summary
7.14.2 Kolltan Pharmaceuticals, Inc. Business Overview
7.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.14.4 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.14.5 Kolltan Pharmaceuticals, Inc. Key News
7.15 Natco Pharma Limited
7.15.1 Natco Pharma Limited Corporate Summary
7.15.2 Natco Pharma Limited Business Overview
7.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.15.4 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.15.5 Natco Pharma Limited Key News
7.16 Nerviano Medical Sciences S.r.l.
7.16.1 Nerviano Medical Sciences S.r.l. Corporate Summary
7.16.2 Nerviano Medical Sciences S.r.l. Business Overview
7.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.16.4 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.16.5 Nerviano Medical Sciences S.r.l. Key News
7.17 Novartis AG
7.17.1 Novartis AG Corporate Summary
7.17.2 Novartis AG Business Overview
7.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.17.4 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.17.5 Novartis AG Key News
7.18 Omeros Corporation
7.18.1 Omeros Corporation Corporate Summary
7.18.2 Omeros Corporation Business Overview
7.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.18.4 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.18.5 Omeros Corporation Key News
8 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Analysis
8.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, 2017-2028
8.2 Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gastrointestinal Stromal Tumor (GIST) Drug Supply Chain Analysis
10.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Value Chain
10.2 Gastrointestinal Stromal Tumor (GIST) Drug Upstream Market
10.3 Gastrointestinal Stromal Tumor (GIST) Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Gastrointestinal Stromal Tumor (GIST) Drug in Global Market
Table 2. Top Gastrointestinal Stromal Tumor (GIST) Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Companies, 2017-2022
Table 5. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Type
Table 9. List of Global Tier 1 Gastrointestinal Stromal Tumor (GIST) Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastrointestinal Stromal Tumor (GIST) Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), 2017-2022
Table 15. By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), 2023-2028
Table 16. By Application ? Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), 2017-2022
Table 20. By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), 2023-2028
Table 21. By Region ? Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), 2017-2022
Table 25. By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), 2023-2028
Table 26. By Country - North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Gastrointestinal Stromal Tumor (GIST) Drug Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Gastrointestinal Stromal Tumor (GIST) Drug Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Gastrointestinal Stromal Tumor (GIST) Drug Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Gastrointestinal Stromal Tumor (GIST) Drug Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales, (K Pcs), 2023-2028
Table 46. Ariad Pharmaceuticals, Inc. Corporate Summary
Table 47. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 48. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Arog Pharmaceuticals, Inc. Corporate Summary
Table 50. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 51. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Array BioPharma Inc. Corporate Summary
Table 53. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 54. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Astex Pharmaceuticals, Inc. Corporate Summary
Table 56. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 57. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Blueprint Medicines Corporation Corporate Summary
Table 59. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 60. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Boston Biomedical, Inc. Corporate Summary
Table 62. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 63. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Calithera Biosciences, Inc. Corporate Summary
Table 65. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 66. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Chipscreen Biosciences Ltd Corporate Summary
Table 68. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 69. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Deciphera Pharmaceuticals, LLC Corporate Summary
Table 71. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 72. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 74. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 75. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Horizon Pharma Plc Corporate Summary
Table 77. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 78. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. Immunicum AB Corporate Summary
Table 80. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 81. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Jiangsu Hengrui Medicine Co., Ltd. Corporate Summary
Table 83. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 84. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. Kolltan Pharmaceuticals, Inc. Corporate Summary
Table 86. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 87. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 88. Natco Pharma Limited Corporate Summary
Table 89. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 90. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 91. Nerviano Medical Sciences S.r.l. Corporate Summary
Table 92. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 93. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 94. Novartis AG Corporate Summary
Table 95. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 96. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 97. Omeros Corporation Corporate Summary
Table 98. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 99. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 100. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 101. Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 102. Global Gastrointestinal Stromal Tumor (GIST) Drug Production by Region, 2017-2022 (K Pcs)
Table 103. Global Gastrointestinal Stromal Tumor (GIST) Drug Production by Region, 2023-2028 (K Pcs)
Table 104. Gastrointestinal Stromal Tumor (GIST) Drug Market Opportunities & Trends in Global Market
Table 105. Gastrointestinal Stromal Tumor (GIST) Drug Market Drivers in Global Market
Table 106. Gastrointestinal Stromal Tumor (GIST) Drug Market Restraints in Global Market
Table 107. Gastrointestinal Stromal Tumor (GIST) Drug Raw Materials
Table 108. Gastrointestinal Stromal Tumor (GIST) Drug Raw Materials Suppliers in Global Market
Table 109. Typical Gastrointestinal Stromal Tumor (GIST) Drug Downstream
Table 110. Gastrointestinal Stromal Tumor (GIST) Drug Downstream Clients in Global Market
Table 111. Gastrointestinal Stromal Tumor (GIST) Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Gastrointestinal Stromal Tumor (GIST) Drug Segment by Type
Figure 2. Gastrointestinal Stromal Tumor (GIST) Drug Segment by Application
Figure 3. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Gastrointestinal Stromal Tumor (GIST) Drug Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Gastrointestinal Stromal Tumor (GIST) Drug Revenue in 2021
Figure 9. By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2017-2028
Figure 19. US Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2017-2028
Figure 24. Germany Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2017-2028
Figure 33. China Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2017-2028
Figure 40. Brazil Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2017-2028
Figure 44. Turkey Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Gastrointestinal Stromal Tumor (GIST) Drug by Region, 2021 VS 2028
Figure 50. Gastrointestinal Stromal Tumor (GIST) Drug Industry Value Chain
Figure 51. Marketing Channels
Industry Market Size
